1. Gradoni L, Lopez-Velez R, Mokni M (2017) Manual on case management and surveillance of the leishmaniases in the WHO European Region. World Health Organization. https://www.euro.who.int/en/publications/abstracts/manual-on-case-management-and-surveillance-of-the-leishmaniases-in-the-who-european-region-2017 Accessed 1 Oct 2019
2. van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J (2014) Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 20:286–299
3. Antinori S, Cascio A, Parravicini C, Bianchi R, Corbellino M (2008) Leishmaniasis among organ transplant recipients. Lancet Infect Dis 8:191–199
4. Alves da Silva A, Pacheco-Silva A, de Castro Sesso R, Esmeraldo RM, Costa de Oliveira CM, Fernandes PF et al (2013) The risk factors for and effects of visceral leishmaniasis in graft and renal transplant recipients. Transplantation 95(5):721–727
5. La Hoz RM, Morris MI, Infectious Diseases Community of Practice of the American Society of Transplantation (2019) Tissue and blood protozoa including toxoplasmosis, Chagas disease, leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients- Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33(9):e13546